여름정기학술대회
2022여름초록
발표자 및 발표 내용
소속 |
|
---|---|
발표구분 |
|
포스터발표 |
|
Brief Oral Presentation 발표신청 |
|
Keyword |
|
주저자
이름 |
|
---|---|
소속 |
|
국가 |
|
공동저자
공동저자 |
|
---|
접수자
이름 |
|
---|---|
소속 |
|
N-nitrosamines (NAs) are classified by the International Agency for Research on Cancer (IARC) and the US Environmental Protection Agency (EPA) according to their degree of carcinogenic risk. In addition, management standards are suggested and regulated by the World Health Organization (WHO) and US Food and Drug Administration (FDA). Based on these control guidances, NAs present in pharmaceuticals are infinitesimal amounts. Recently, various analysis methods using LC or GC combined with MS analysis methods have been proposed to manage trace amounts of N-nitrosamine present in pharmaceuticals. However, we observed the formation of a huge amount of NDMA in situ reaction with high temperature applied during HS-GC-MS system for some drugs such as metformin, nizatidine and ranitidine. This can lead to overestimation NAs quantification results and low reproducibility. To prevent the artificial formation of NAs during HS-GC-MS analysis, we developed a method by adding a nitrite scavenger capable of removing nitrites and nitrates to the API and drugs. Among various nitration inhibitors such as ascorbic acid, caffeic acid, and cysteine were applied to prevent the artificial formation of NAs. Headspce GC-MS conditions were optimized by testing incubation temperature, incubation time, concentration of each scavenger reagent, spike volume, and sample volume. The established HS-GC-MS method will help in the accurate quantification of NAs in various APIs and pharmaceuticals to reduce the in-situ formation of NAs.
게시물수정
게시물 수정을 위해 비밀번호를 입력해주세요.
댓글삭제게시물삭제
게시물 삭제를 위해 비밀번호를 입력해주세요.